CHICAGO – April 29, 2021 – The American Health Information Management Association (AHIMA) announced today the creation of AHIMA dHealth™ (AHIMAdHealth.org), a solution where providers and other healthcare stakeholders can discover digital health products, including ones that have passed an AHIMA assessment showing they secure and protect patient data.
AHIMA is working with Moxe, a clinical data clearinghouse focusing on interoperability solutions, to develop AHIMA dHealth™. Through the AHIMA dHealth™ Assessment, providers now have a reputable resource they can turn to for critical information about a digital health product's privacy and data security practices and policies. All AHIMA dHealth™ Approved digital health products that pass the assessment will be listed in an online directory that providers can use to verify the product has earned the designation.
The AHIMA dHealth™ Assessment is especially relevant in light of recent regulatory changes in the U.S. that give patients more access and power over their health information. Last year, the Office of the National Coordinator for Health Information Technology (ONC) finalized the Cures Act Final Rule, which requires hospitals and providers to adopt standardized application programming interfaces (APIs) that allow individuals to access and use electronic health information without special effort on the part of the patient. This means patients now have the power to direct providers to share their health records with third-party digital health products, including consumer health apps.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
To become AHIMA dHealth™ Approved, digital health companies must complete a self-reported assessment based upon AHIMA standards and best practices for privacy and data security. The assessment is particularly relevant for digital health products that are not regulated by the Health Insurance Portability and Accountability Act (HIPAA).
AHIMA CEO Wylecia Wiggs Harris, PhD, CAE, said the program will make it easier and simpler for providers to grant patient information requests. AHIMA has long advocated for the rights of patients to access their health information and released a policy statement last year saying, "AHIMA supports the right of individuals to access their accurate and complete health information in a timely manner."
"Through AHIMA dHealth™, we're assessing digital health products so providers can spend more time focused on patient care and discern risk more quickly," Harris said. "Providers will have to place fewer requests in their 'need to review' funnel, as they can use the AHIMA dHealth™ directory to easily see which digital health products are AHIMA dHealth™ Approved. I believe this program will make it easier for providers to comply with the Cures Act Final Rule."